A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway

Table 1

Ligand with its binding energy values from docking studies.

Name	Electrostatic energy	Van der waals energy	Cdocker energy	Cdocker_interaction energy	Calculate binding energy	H-bond count	Interacting amino acids
Ruthenium-fluvastatin	-23.168	3.03	-234.9	45.31	-56.3119	2	Thr59,Asn64, Val66, Ser67, Glu68, Val71